Efficacy of Immediate Allogeneic Hematopoietic Stem Cell Transplantation Versus Bridging Therapy Followed by Transplantation in Higher-Risk Myelodysplastic Syndrome Patients
Clinical trial NCT06918834 · RECRUITING
Trial details
- NCT number
- NCT06918834
- Sponsor
- Institute of Hematology & Blood Diseases Hospital, China
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-07-24
- Primary completion
- 2028-04-01
- Enrollment
- 236
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.